RIDA®Xplore
Our Flagship Solution
The RIDA®Xplore is R-Biopharm Australia’s flagship Multiplex Tandem PCR (MT-PCR) platform, delivering reliable, automated molecular diagnostics for laboratories with low to medium throughput requirements. Designed to detect multiple clinically relevant pathogens from a single sample with exceptional sensitivity and specificity, the system streamlines syndromic testing while reducing hands-on time and improving workflow consistency. Its compact footprint, intuitive operation and dependable performance make the RIDA®Xplore an ideal solution for routine molecular diagnostic laboratories.
Features & Benefits
- Test up to 24 samples per run
- Small footprint – requires less than 1m of bench space
- Separate preamplification and real-time PCR allows optimal efficiency
- Automatic results calling
- UV deck minimises contamination risks
Efficient Workflow Performance
The RIDA®Xplore has been developed to help laboratories maximise productivity without increasing workflow complexity. By automating key stages of the MT-PCR process, the system reduces manual intervention while maintaining consistent, reproducible results across every run. Laboratories can efficiently process up to 24 samples in a single workflow with minimal hands-on time, allowing staff to focus on result interpretation and other critical laboratory tasks. This combination of automation, flexibility and reliable performance supports faster turnaround times and improved operational efficiency in routine molecular diagnostics.
Dependable Automation for Reliable Molecular Detection
The RIDA®Xplore combines intelligent automation with R-Biopharm’s Multiplex Tandem PCR technology to deliver highly sensitive and specific detection of multiple genetic targets. By separating the pre-amplification and real-time PCR stages, the system minimises target competition and enhances assay performance, enabling accurate multiplex analysis without compromising reliability. Automated result interpretation, integrated quality controls and intuitive software further simplify daily laboratory operations while supporting confidence in every diagnostic result.
Compact Design, Practical Performance
Designed to fit seamlessly into modern laboratory environments, the RIDA®Xplore combines a compact footprint with an intuitive user experience that simplifies routine molecular testing. Quick system setup, user-friendly reagent loading and automated workflow management reduce training requirements and minimise operator variability, making the platform suitable for laboratories of varying sizes and experience levels. Its efficient use of bench space, together with reliable day-to-day operation, allows laboratories to expand molecular testing capabilities without major infrastructure changes.
| Dimensions | 94 W x 58 D x 39 H cm (77 H cm With Door Open) |
| Weight | 30kg (approx.) |
| Total Footprint | 100cm (Includes RIDA®Xplore Processor, RIDA®Cycler 384, PC) |
| Processing Capacity | 1 – 24 Samples per Run |
| Throughput / 8hr Shift | Up to 96 Samples |
| Total Processing Time | 3 hrs 30 mins |
| Protocols | Preinstalled |
| Power Supply | 110 – 240V, 50/60Hz |
Advanced MT-PCR Technology for Routine Molecular Diagnostics
The RIDA®Xplore has been engineered to provide laboratories with a dependable, medium-throughput molecular diagnostic platform that combines automation, flexibility and analytical performance. From streamlined MT-PCR processing to automated result interpretation, the system supports efficient syndromic testing while delivering the accuracy, consistency and reliability required for today’s clinical laboratories. Backed by R-Biopharm Australia’s local expertise, the RIDA®Xplore provides a trusted solution for laboratories seeking to optimise molecular diagnostic workflows.
Systems are intended for in vitro diagnostics use by authorised clinical testing laboratories in Australia, New Zealand, Great Britain, and the European Economic Area, and are included on the Australian Register of Therapeutic Goods (ARTG), the MHRA database (REF: 10541) and compliant with the European Regulation (EU) 2017/746 . In the USA: For Research Use Only (RUO), not for use In diagnostic procedures.
